As of 2025-07-09, the EV/EBITDA ratio of Genomic Vision SA (GV.PA) is -0.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GV.PA's latest enterprise value is 1.66 mil EUR. GV.PA's TTM EBITDA according to its financial statements is -7.39 mil EUR. Dividing these 2 quantities gives us the above GV.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.0x - 11.2x | 9.1x |
| Forward P/E multiples | 10.2x - 11.2x | 10.7x |
| Fair Price | (0.20) - (0.22) | (0.19) |
| Upside | -11085.5% - -12148.8% | -10766.5% |
| Date | EV/EBITDA |